Results 11 to 20 of about 21,775 (287)

Compass Fundus-Guided Perimetry in Geographic Atrophy [PDF]

Journal of Ophthalmology, 2022
Purpose. To evaluate compass (CMP), a recently introduced device that combines scanning ophthalmoscopy, automated perimetry, and eye tracking, for fundus-guided perimetry (microperimetry) with the purpose of correlating perimetric retinal sensitivity ...
Roberta Farci, Arturo Carta, Paolo Fogagnolo, Luca Mario Rossetti, Maurizio Fossarello   +4 more
doaj   +2 more sources

αA crystallin may protect against geographic atrophy-meta-analysis of cataract vs. cataract surgery for geographic atrophy and experimental studies. [PDF]

PLoS ONE, 2012
BACKGROUND: Cataract and geographic atrophy (GA, also called advanced "dry" age-related macular degeneration) are the two major causes of visual impairment in the developed world.
Peng Zhou, Hong-Fei Ye, Yong-Xiang Jiang, Jin Yang, Xiang-Jia Zhu, Xing-Huai Sun, Yi Luo, Guo-Rui Dou, Yu-Sheng Wang, Yi Lu   +9 more
doaj   +2 more sources

GEOGRAPHIC ATROPHY [PDF]

Retina, 2016
There is a lack of agreement regarding the types of lesions and clinical conditions that should be included in the term "geographic atrophy." Varied and conflicting views prevail throughout the literature and are currently used by retinal experts and other health care professionals.We reviewed the nominal definition of the term "geographic atrophy" and
Steffen, Schmitz-Valckenberg, Srinivas, Sadda, Giovanni, Staurenghi, Emily Y, Chew, Monika, Fleckenstein, Frank G, Holz   +5 more
openaire   +3 more sources

Association of Anti-VEGF Injections with Progression of Geographic Atrophy

Ophthalmology and Eye Diseases, 2016
Age-related macular degeneration (AMD) is one of the leading causes of blindness in developed countries in people over the age of 60 years. One of the forms of advanced AMD is wet AMD.
Ryan Enslow, Sai Bhuvanagiri, Sravanthi Vegunta, Benjamin Cutler, Michael Neff, Brian Stagg   +5 more
doaj   +3 more sources

Quantitative multimodal imaging of extensive macular atrophy with pseudodrusen and geographic atrophy with diffuse trickling pattern

Scientific Reports, 2023
To compare clinical and imaging characteristics of extensive macular atrophy with pseudodrusen-like appearance (EMAP) versus diffuse-trickling geographic atrophy (DTGA) and non-diffuse-trickling geographic atrophy (nDTGA) phenotypes of age-related ...
Alessio Antropoli, Alessandro Arrigo, Lorenzo Bianco, Alessandro Berni, La Franca Lamberto, Andrea Saladino, Francesco Bandello, Maurizio Battaglia Parodi   +7 more
doaj   +2 more sources

Clinical Characteristics and Progression of Pachychoroid and Conventional Geographic Atrophy

Ophthalmology Science
Purpose: To elucidate the clinical characteristics and progression rates of pachychoroid and conventional geographic atrophy (GA). Design: Retrospective, multicenter, observational study.
Yukiko Sato, MD, Naoko Ueda-Arakawa, MD, PhD, Ayako Takahashi, MD, PhD, Masahiro Miyake, MD, PhD, Yuki Mori, MD, PhD, Yasunori Miyara, MD, Chikako Hara, MD, PhD, Yoko Kitajima, MD, Ruka Maruko, MD, PhD, Moeko Kawai, MD, Hajime Takahashi, MD, PhD, Hideki Koizumi, MD, PhD, Maiko Maruyama-Inoue, MD, PhD, Yasuo Yanagi, MD, PhD, Tomohiro Iida, MD, PhD, Kanji Takahashi, MD, PhD, Taiji Sakamoto, MD, PhD, Akitaka Tsujikawa, MD, PhD   +17 more
doaj   +3 more sources

GEOGRAPHIC ATROPHY IN RETINAL ANGIOMATOUS PROLIFERATION

Retina, 2011
To describe the occurrence of geographic atrophy in patients with retinal angiomatous proliferation (RAP).Demographics, visual acuity, color fundus photographs, fluorescein and indocyanine green angiograms, and fundus autofluorescence and near-infrared autofluorescence images were reviewed in 53 patients (66 eyes) with RAP.Of 53 treatment-naive eyes ...
McBain, V.A., Kumari, R., Lois, N., Townend, J.   +3 more
openaire   +5 more sources

Gradeability and Reproducibility of Geographic Atrophy Measurement in GATHER-1, a Phase II/III Randomized Interventional Trial

Ophthalmology Science
Objective: To validate GATHER-1 inclusion criteria and the study’s primary anatomic end point by assessing the reproducibility of geographic atrophy (GA) measurements and factors that affect reproducibility.
Angela S. Li, MD, Justin Myers, BS, Sandra S. Stinnett, DrPH, Dilraj S. Grewal, MD, Glenn J. Jaffe, MD   +4 more
doaj   +3 more sources

Potential role of lampalizumab for treatment of geographic atrophy

Clinical Ophthalmology, 2015
William Rhoades, Drew Dickson, Diana V Do Truhlsen Eye Institute, Department of Ophthalmology and Visual Sciences, University of Nebraska Medical Center, Omaha, NE, USA Abstract: The purpose of this article is to review the pathways underlying age ...
Rhoades W, Dickson D, Do DV
doaj   +1 more source

Clinical Outcomes of Treatment of Geographic Atrophy: A Narrative Review [PDF]

Ophthalmology and Therapy
Rationale In 2023, the U.S. Food and Drug Administration approved pegcetacoplan (SYFOVRE) as the first therapeutic option for geographic atrophy (GA), a previously untreatable condition associated with age-related macular degeneration.
Anne Helene Køllund Nissen, Thomas Lee Torp, Anna Stage Vergmann   +2 more
doaj   +2 more sources